Approval · Notice of Compliance 27486 · 2022
EDECRIN: Notice of Compliance 27486
Issued January 27, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27486
- Date
- January 27, 2022
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to Bottle Labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EDECRIN | Not yet assigned | — |
Medicinal ingredients
- ETHACRYNIC ACID 25 MG per TAB